SHH Equity Snapshot

603087 Weekly Equity Report

Gan & Lee Pharmaceuticals.

Interactive chart JSON snapshot
Latest Close 55.62 CNY 12 Jun 2026
1W Return 1.9% latest completed week
4W Return 0.3% short-term follow-through
12W Return -5.0% quarterly tape
Trend Breadth 67.3% 35 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
Company Brief

What the company does

Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China. Its products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro injection; Prandilin 25, an insulin lispro mix 75/25 injection; Rapilin, an insulin aspart injection; Rapilin 30, an insulin aspart 30 injection; and Similin 30, a mixed protamine human insulin injection. The company also offers GanleePen, an insulin injection device; GanleeFine, an insulin pen needle; and other medical devices. The company was formerly known as Beijing Gan & …

Snapshot

What the weekly tape is saying

603087 closed the latest completed week at 55.62 CNY. The 4-week return is 0.3% and the 12-week return is -5.0%. Trend Signal is inactive, Market Dynamics is -1.11. Setup signature: Risk-first tape with a 30/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -10.5%
Volume 0.9x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 37 Persistence of active Trend Signal over the last year and current streak.
Momentum 46 Blend of 4-week and 12-week follow-through.
Dynamics 31 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 7 Relative leadership and short-term RS change.
Volume 40 Participation compared with the 13-week volume baseline.
Risk Control 17 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
62.17 CNY
Vs Trend Line
-10.5%
Fair Value
49.68 CNY
Vs Fair Value
11.9%
52W High
80.70 CNY
52W Low
51.02 CNY
Drawdown
-31.1%
Range Position
15.5%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 1.9%
4W 0.3%
12W -5.0%
26W -10.9%
52W 2.4%

Trend read

Active Streak
0 weeks
52W Active Weeks
35
52W Active Breadth
67.3%
Sector Scope
CN Healthcare
Sector Rank
78 of 486
Sector Percentile
84.1%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-1.11
4W MD Change
13.3%
Relative Strength
-14.77
4W RS Change
17.4%
Expectation
Undecided
Probability
47.63%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
29.8M
13W Average
31.4M
52W Average
51.0M
Vs 13W
0.9x
Vs 52W
0.6x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
3.7%
52W Volatility
4.2%
Upside Weeks
27
Downside Weeks
25
Downside Breadth
48.1%
Avg Gain / Loss
3.3% / -3.3%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
SHH
Country
CN
Sector
Healthcare
Industry
Medical Instruments & Supplies
Currency
CNY
Market Cap
32.8B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 55.62 CNY 1.9% 62.17 CNY 49.68 CNY -1.11 -14.77 29.8M Off
5 Jun 2026 54.58 CNY 4.4% 62.41 CNY 49.56 CNY -1.21 -16.51 32.7M Off
29 May 2026 52.28 CNY -1.5% 62.81 CNY 49.44 CNY -1.30 -21.03 28.5M Off
22 May 2026 53.08 CNY -4.3% 63.32 CNY 49.32 CNY -1.34 -20.84 31.9M Off
15 May 2026 55.47 CNY -6.0% 63.82 CNY 49.21 CNY -1.28 -17.89 33.1M Off
8 May 2026 59.01 CNY 2.2% 64.39 CNY 49.08 CNY -1.15 -13.73 16.9M Off
1 May 2026 57.74 CNY -2.6% 64.91 CNY 48.92 CNY -1.03 -14.18 22.9M Off
24 Apr 2026 59.27 CNY -7.3% 65.53 CNY 48.79 CNY -0.84 -11.26 45.7M Off
17 Apr 2026 63.92 CNY 1.6% 65.88 CNY 48.65 CNY -0.80 -3.42 32.3M Off
10 Apr 2026 62.91 CNY 1.5% 66.17 CNY 48.47 CNY -0.94 -3.07 23.3M Off
3 Apr 2026 61.96 CNY 2.3% 66.52 CNY 48.29 CNY -0.95 -1.64 44.8M Off
27 Mar 2026 60.56 CNY 3.5% 66.84 CNY 48.11 CNY -0.89 -4.38 39.9M Off
20 Mar 2026 58.53 CNY -4.0% 67.07 CNY 47.94 CNY -0.82 -8.31 26.7M Off
13 Mar 2026 60.96 CNY -2.4% 67.16 CNY 47.79 CNY -0.64 -7.56 19.5M Off